Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics

Stem Cells and Development

Volumn 22, Issue 3, 2013, Pages 444-458

  Moschidou, Dafni ^a   Mukherjee, Sayandip ^b   Blundell, Michael P ^b   Jones, Gemma N ^a   Atala, Anthony J ^c   Thrasher, Adrian J ^b   Fisk, Nicholas M ^d   De Coppi, Paolo ^b   Guillot, Pascale V ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 4; TELOMERASE; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; VALPROIC ACID;

AMNION FLUID; ARTICLE; CELL GROWTH; CELL STRUCTURE; EMBRYO; EMBRYOID BODY; EMBRYONIC STEM CELL; FEMALE; FLOW CYTOMETRY; GERM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MESENCHYMAL STEM CELL; NUCLEAR REPROGRAMMING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLURIPOTENT STEM CELL; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TERATOMA; UPREGULATION;

AMNIOTIC FLUID; ANIMALS; ANTIGENS, DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; CULTURE MEDIA; EMBRYONIC STEM CELLS; FEMALE; GENE EXPRESSION; HISTONE DEACETYLASE INHIBITORS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MESENCHYMAL STROMAL CELLS; MICE; NEOPLASMS, EXPERIMENTAL; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROTO-ONCOGENE PROTEINS C-MYC; SOXB1 TRANSCRIPTION FACTORS; TELOMERE; TERATOMA; UP-REGULATION; VALPROIC ACID;

EID: 84872728325     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0267     Document Type: Article

References (27)

1. Kaviani A, TE Perry, A Dzakovic, RW Jennings, MM Ziegler and DO Fauza. (2001). The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg 36:1662-1665.
2. In 't Anker PS, SA Scherjon, C Kleijburg-van der Keur, WA Noort, FH Claas, R Willemze, WE Fibbe and HH Kanhai. (2003). Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102:1548-1549.
3. Kaviani A, K Guleserian, TE Perry, RW Jennings, MM Ziegler and DO Fauza. (2003). Fetal tissue engineering from amniotic fluid. J Am Coll Surg 196:592-597.
4. Prusa AR, E Marton, M Rosner, G Bernaschek and M Hengstschlager. (2003). Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod 18:1489-1493.
5. Tsai MS, JL Lee, YJ Chang and SM Hwang. (2004). Isolation of human multipotent mesenchymal stem cells from secondtrimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 19:1450-1456.
6. Bossolasco P, T Montemurro, L Cova, S Zangrossi, C Calzarossa, S Buiatiotis, D Soligo, S Bosari, V Silani, et al. (2006). Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res 16:329-336.
7. De Coppi P, G Bartsch, Jr., MM Siddiqui, T Xu, CC Santos, L Perin, G Mostoslavsky, AC Serre, EY Snyder, et al. (2007). Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25:100-106.
8. Karlmark KR, A Freilinger, E Marton, M Rosner, G Lubec and M Hengstschlä ger. (2005). Activation of ectopic Oct-4 and Rex-1 promoters in human amniotic fluid cells. Int J Mol Med 16:987-992.
9. Liu H, DQ Liu, BW Li, LD Guan, ZF Yan, YL Li, XT Pei, W Yue, M Wang, et al. (2011). Human amniotic fluid-derived stem cells can differentiate into hepatocyte-like cells in vitro and in vivo. In Vitro Cell Dev Biol Anim 47:601-608.
10. Benavides OM, JJ Petsche, KJ Moise, Jr., A Johnson and JG Jacot. (2012). Evaluation of endothelial cells differentiated from amniotic fluid-derived stem cells. Tissue Eng Part A 18:1123-1131.
11. Wolfrum K, Y Wang, A Prigione, K Sperling, H Lehrach and J Adjaye. (2010). The LARGE principle of cellular reprogramming: lost, acquired and retained gene expression in foreskin and amniotic fluid-derived human iPS cells. PloS One 5:e13703.
12. Moschidou D and PV Guillot. (2012). Reprogramming human amniotic fluid stem cells to functional pluripotency by manipulation of culture conditions. Nat Protoc Exchange. [Epub ahead of print]; DOI:10.1038/protex.2012.032.
13. Moschidou D, S Mukherjee, MP Blundell, K Drews, GN Jones, H Abdulrazzak, B Nowakowska, A Phoolchund, Lay K, et al. (2012). Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther 20:1953-1967.
14. Chaturvedi G, PD Simone, R Ain, MJ Soares and MW Wolfe. (2009). Noggin maintains pluripotency of human embryonic stem cells grown on Matrigel. Cell Prolif 42:425-433.
15. Guillot PV, C Gotherstrom, J Chan, H Kurata and NM Fisk. (2007). Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25:646-654.
16. Chen YS, RA Pelekanos, RL Ellis, R Horne, EJ Wolvetang and NM Fisk. (2012). Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells. Stem Cells Transl Med 1:83-95.
17. Lee A, J Deutinger and G Bernaschek (1994). "Voluvision": three-dimensional ultrasonography of fetal malformations. Am J Obstet Gynecol 170:1312-1314.
18. Sundberg M, L Jansson, J Ketolainen, H Pihlajamaki, R Suuronen, H Skottman, J Inzunza, O Hovatta and S Narkilahti. (2009). CD marker expression profiles of human embryonic stem cells and their neural derivatives, determined using flow-cytometric analysis, reveal a novel CD marker for exclusion of pluripotent stem cells. Stem Cell Res 2:113-124.
19. Hezroni H, BS Sailaja and E Meshorer. (2011). Pluripotencyrelated, valproic acid (VPA)-induced genome-wide histone H3 lysine 9 (H3K9) acetylation patterns in embryonic stem cells. J Biol Chem 286:35977-35988.
20. Huangfu D, K Osafune, R Maehr, W Guo, A Eijkelenboom, S Chen, W Muhlestein and DA Melton. (2008). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26: 1269-1275.
21. Hezroni H, I Tzchori, A Davidi, A Mattout, A Biran, M Nissim-Rafinia, H Westphal and E Meshorer. (2011). H3K9 histone acetylation predicts pluripotency and reprogramming capacity of ES cells. Nucleus 2:300-309.
22. Durcova-Hills G, F Tang, G Doody, R Tooze and MA Surani. (2008). Reprogramming primordial germ cells into pluripotent stem cells. PloS One 3:e3531.
23. Hayashi K, SM de Sousa Lopes and MA Surani. (2007). Germ cell specification in mice. Science 316:394-396.
24. Moore FL, J Jaruzelska, MS Fox, J Urano, MT Firpo, PJ Turek, DM Dorfman and RA Pera. (2003). Human Pumilio-2 is expressed in embryonic stem cells and germ cells and interacts with DAZ (Deleted in AZoospermia) and DAZ-like proteins. Proc Natl Acad Sci USA 100: 538-543.
25. Ancelin K, UC Lange, P Hajkova, R Schneider, AJ Bannister, T Kouzarides and MA Surani. (2006). Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. Nat Cell Biol 8:623-630.
26. Castrillon DH, BJ Quade, TY Wang, C Quigley and CP Crum. (2000). The human VASA gene is specifically expressed in the germ cell lineage. Proc Natl Acad Sci USA 97:9585-9590.
27. Kucia M, B Machalinski and MZ Ratajczak. (2006). The developmental deposition of epiblast/germ cell-line derived cells in various organs as a hypothetical explanation of stem cell plasticity? Acta Neurobiol Exp (Wars) 66:331-341.